AGP Executive Report
Last update: 6 hours agoHepatitis B breakthrough: Singapore-linked researchers report an experimental hepatitis B drug (bepirovirsen) may deliver a “functional cure” for about 1 in 5 patients, with longer-term durability still under study. Cancer screening at home: Manulife Singapore will offer Guardant Health’s Shield™ multi-cancer blood test to eligible customers from May 2026, boosting early detection options alongside existing tumour testing access. AI safety in daily life: StarHub plans SIM-based IDs for AI agents as a “kill switch” style governance layer, aiming to curb rogue behaviour and protect sensitive data during real-time autonomous tasks. Wearables to action: Singapore health tech Signsbeat is testing a model that links wearable signals with metabolic stability and recovery patterns, moving beyond passive tracking toward personalised recommendations. Longevity & recovery plans: Rapid Group launches clinically led personalised recovery and longevity programmes across its physiotherapy, Pilates and recovery brands. Community wellness event: Friends of Parrots Day returns on 30 May at Jurong Lake Gardens with talks and booths on responsible parrot care. Public health & safety: A woman was jailed for shoving a schoolgirl at Buona Vista MRT; separately, a Malaysian man was charged in Singapore for a lift murder in Choa Chu Kang.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.